JNBJ

ASCO: J&J, Legend reveal more CAR-T data and a look at Carvykti for earlier myeloma in a difficult population
Fierce Pharma
Fri, 05/27/22 - 10:33 am
ASCO 2022
JNBJ
Legend Biotech
Carvykti
CAR-T
Multiple Myeloma